JPMorgan Chase & Co. Cuts iTeos Therapeutics (NASDAQ:ITOS) Price Target to $15.00
iTeos Therapeutics (NASDAQ:ITOS – Free Report) had its target price lowered by JPMorgan Chase & Co. from $22.00 to $15.00 in a research note released on Thursday morning,Benzinga reports. The firm currently has an overweight rating on the stock. Other equities analysts have also recently issued reports about the company. Wells Fargo & Company dropped […]
iTeos Therapeutics (NASDAQ:ITOS – Free Report) had its target price lowered by JPMorgan Chase & Co. from $22.00 to $15.00 in a research note released on Thursday morning,Benzinga reports. The firm currently has an overweight rating on the stock. Other equities analysts have also recently issued reports about the company. Wells Fargo & Company dropped […]
